Market research
GNN.F GN Store Nord A/S
F EUR Healthcare
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 2B
- P/E ratio
- Not available
- Analyst target
- 575
- Dividend yield
- Not available
- Beta
- 1.35
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- DK0010272632
- Market cap
- 2B
- P/E ratio
- Not available
- Analyst target
- 575
- Dividend yield
- Not available
- Beta
- 1.35
About
About GN Store Nord A/S
GN Store Nord A/S provides hearing, audio, video, and gaming solutions in Denmark, Europe, North America, and internationally. The company operates through Hearing, Enterprise, and Gaming segments. The Hearing segment produces and sells hearing instruments and products. The Enterprise segment supplies audio and video devices for professional use. The Gaming segment produces gaming devices and peripherals. It offers its products under the ReSound, Beltone, Interton, Danavox, Jabra Enhance, Jabra, BlueParrott, FalCom, SteelSeries, and KontrolFreek brands. GN Store Nord A/S was founded in 1869 and is based in Ballerup, Denmark.
Research context
GN Store Nord A/S appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the GNN.F discussion.
5 years, 7 months ago
GN Store Nord A/S is currently in a long term uptrend where the price is trading 16.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.8.
GN Store Nord A/S's total revenue rose by 10.9% to $4B since the same quarter in the previous year.
Its net income has dropped by 5.2% to $527M since the same quarter in the previous year.
Finally, its free cash flow grew by 288.7% to $1B since the same quarter in the previous year.
Based on the above factors, GN Store Nord A/S gets an overall score of 4/5.